Brief: Sedana Medical Applies For Market Approval In Italy
Dec 22 (Reuters) - Sedana Medical AB (publ) SEDANA.ST :
* SEDANA MEDICAL APPLIES FOR MARKET APPROVAL IN ITALY
* SUBMITTED AN APPLICATION FOR MARKET APPROVAL FOR SEDACONDA
FOR
INHALED SEDATION IN INTENSIVE CARE IN ITALY
* WE ARE AIMING TO RECEIVE FURTHER APPROVALS IN POLAND,
ITALY,
SWITZERLAND, AND UK DURING 2022
Source text for Eikon: ID:nWkr5QrXwH
Further company coverage: SEDANA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Sedana Medical AB (publ)
See all newsSweden's Sedana Medical Q3 sales rise as growth returns
Brief: Sedana Medical Announces PDUFA Target Action Date
Brief: Sedana Medical Announces FDA Acceptance For Review Of Its New Drug Application In U.S.
Sweden's Sedana Medical Q2 sales flat, EBITDA loss narrows
Brief: Sedana Medical Q2 EBITDA Loss Narrows To SEK 1.9 Mln